|
ArixtraDrug - Arixtra The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; SUBCUTANEOUS
Active Ingredient(s) -
Fondaparinux Sodium
Strength -
7.5MG/0.6ML
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
021345
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
May 28, 2004
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Glaxosmithkline
Arixtra
Antizol 1gm/ml Injectable; Injection
Vitravene Preservative Free 6.6mg/ml Injectable; Injection Arixtra 10mg/0.8ml Injectable; Subcutaneous Arixtra 2.5mg/0.5ml Injectable; Subcutaneous Arixtra 5mg/0.4ml Injectable; Subcutaneous Arixtra 7.5mg/0.6ml Injectable; Subcutaneous Gonal-f Rff 75 Iu/vial Injectable; Subcutaneous Gonal-f Rff Pen 300 Iu/0.5ml Injectable; Subcutaneous Gonal-f Rff Pen 450 Iu/0.75ml Injectable; Subcutaneous Gonal-f Rff Pen 900 Iu/1.5ml Injectable; Subcutaneous NewDrugInformation |